Surface TRAIL Decoy Receptor-4 Expression Is Correlated With TRAIL Resistance in McF7 Breast Cancer Cells

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-5-54
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated With Upregulated Decoy TRAIL Receptor Expression in Patients With Multiple Myeloma

PLoS ONE
Multidisciplinary
2015English

Progressive Resistance of BTK-143 Osteosarcoma Cells to Apo2L/TRAIL-induced Apoptosis Is Mediated by Acquisition of DcR2/TRAIL-R4 Expression: Resensitisation With Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2003English

Glutamine Metabolism Regulates FLIP Expression and Sensitivity to TRAIL in Triple-Negative Breast Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Resistance to TRAIL in Mantle Cell Lymphoma Cells Is Associated With the Decreased Expression of Purine Metabolism Enzymes

International Journal of Molecular Medicine
MedicineGenetics
2013English

Increased TRAIL and TRAIL Receptor Expression in Rat Corneal Stroma Exposed to Chemical Burn Damage

Acta Ophthalmologica
MedicineOphthalmology
2018English

SKP2 Confers Resistance of Pancreatic Cancer Cells Towards TRAIL-induced Apoptosis

International Journal of Oncology
Cancer ResearchOncology
2010English

Novel Targets for Sensitizing Breast Cancer Cells to TRAIL-Induced Apoptosis With siRNA Delivery

International Journal of Cancer
Cancer ResearchOncology
2017English

Targeting C-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors

PLoS ONE
Multidisciplinary
2014English

Chemokine Receptor 4 Expression Is Correlated With the Occurrence and Prognosis of Gastric Cancer

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy